[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 16, Issue 3 (10-2014) ::
J Gorgan Univ Med Sci 2014, 16(3): 49-55 Back to browse issues page
Effect of valproic acid and radiotherapy on viability of MCF-7 breast cancer cell line
Aghagolzade Haji H1 , Khoshbin Khoshnazar AR2 , Gharaei R3 , Javan B4 , Asadi J * 5
1- M.Sc in Clinical Biochemstry, Faculty of Medicine, Golestan University of Medical Science, Gorgan, Iran
2- Associate Professor, Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Science, Gorgan, Iran
3- M.Sc in Molecular Biology, Faculty of Medicine, Golestan University of Medical Science, Gorgan, Iran
4- Ph.D Candidate in Molecular Medicine, Faculty of Advanced Medical Technologies, Golestan University of Medical Science, Gorgan, Iran
5- Assistant Professor, Department of Biochemistry and Biophysics, Metabolic Disorders Research Center, Faculty of Medicine, Golestan University of Medical Science, Gorgan, Iran , ja_asadi52@yahoo.com
Abstract:   (13214 Views)
Background and Objective: Valproic acid is used in the epilepsy, bipolar and migraine therapy. As a histone deacetylase inhibitor, Valproic acid has been recently under investigation in cancer treatment, either alone or in combination with either chemotherapy or radiotherapy. This study was done to determine the effect of Valproic acid and radiotherapy on viability of MCF-7 breast cancer cell line. Methods: In this descriptive - analytic study, MCF-7 cell line was obtained from the Iranian Pasteur Institute. The cells were treated and incubated by different concentrations of Valproic acid (1, 2, 4, 8, 16, 32, 64 and 128 mM) either alone or in combination with various dosages (0 .5, 2, 4, 6 and 8 Gray) of radiotherapy. After cell viability assay, using the Neutral red staining, the most nearest results to LD50 were selected. Cell viability was evaluated with trypan blue staining. Results: The most nearest concentrations of LD50 was doses of 2, 8 and 16 mM of valproic acid and dosage of Gray 4 of radiation. There was a significant dose-dependent correlation between reduction of cell viability with valproic acid concentration (P<0.05). Conclusion: Valproic acid, either alone or combination with radiotherapy caused a significant decline in the cell viability of MCF-7 breast cancer cell line.
Keywords: Breast cancer, MCF-7 cell line, Valproic acid, Radiotherapy, Cell viability
Full-Text [PDF 696 kb] [English Abstract]   (12900 Downloads)    
Type of Study: Original Articles | Subject: Biochemistry
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aghagolzade Haji H, Khoshbin Khoshnazar AR, Gharaei R, Javan B, Asadi J. Effect of valproic acid and radiotherapy on viability of MCF-7 breast cancer cell line. J Gorgan Univ Med Sci 2014; 16 (3) :49-55
URL: http://goums.ac.ir/journal/article-1-2120-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 3 (10-2014) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 35 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)